Ladich Elena, Nakano Masataka, Carter-Monroe Naima, Virmani Renu
CVPath, Institute Inc, Gaithersburg, MD 20878, USA.
Future Cardiol. 2011 Sep;7(5):629-42. doi: 10.2217/fca.11.53.
With the aging of the general population in industrialized nations, calcific aortic stenosis (CAS) is becoming an increasingly important medical problem. The etiology is for the most part, dependent on the age at presentation; the two predominant causes in the western world are calcific aortic valve disease arising in a tricuspid aortic valve and bicuspid aortic valve (BAV). CAS is a progressive disease, exhibiting a spectrum of pathologic findings, ranging from valvular sclerosis to severe nodular calcification. Aortic valve replacement is the recommended treatment for severe disease but tissue valves may also calcify over time. Various atherosclerotic risk factors have been linked to aortic stenosis and there are mechanistic similarities between atherosclerosis and CAS. The precise pathologic mechanisms underlying aortic stenosis are poorly understood.
随着工业化国家总体人口的老龄化,钙化性主动脉瓣狭窄(CAS)正成为一个日益重要的医学问题。其病因在很大程度上取决于发病时的年龄;在西方世界,两个主要病因是三尖瓣主动脉瓣和二叶式主动脉瓣(BAV)出现的钙化性主动脉瓣疾病。CAS是一种进行性疾病,表现出一系列病理表现,从瓣膜硬化到严重的结节状钙化。对于严重疾病,推荐的治疗方法是主动脉瓣置换,但生物组织瓣膜也可能随时间钙化。各种动脉粥样硬化危险因素已与主动脉瓣狭窄相关联,并且动脉粥样硬化和CAS之间存在机制上的相似性。主动脉瓣狭窄背后的确切病理机制尚不清楚。